Oral Potassium Administration in Pediatric Patients with Hypokalemia

Dosing Guidelines

For pediatric patients with hypokalemia, oral potassium should be administered at a dose of 1-3 mmol/kg/day divided into multiple doses, with careful monitoring of serum potassium levels to prevent complications, as recommended by the American Journal of Kidney Diseases 1, 2
For infants and young children, potassium supplementation should be started at 1-3 mmol/kg/day (40-120 mg/kg/day) divided into multiple doses, according to the American Journal of Kidney Diseases 1

Potassium supplements should be given with adequate fluid intake to ensure proper absorption and prevent gastrointestinal irritation, as suggested by the American Journal of Kidney Diseases 1
Potassium supplements should be administered with or after meals to minimize gastrointestinal side effects, as recommended by the American Journal of Kidney Diseases 1

Verify potassium levels with a second sample to rule out spurious hyperkalemia from hemolysis during phlebotomy, as advised by the Journal of Clinical Oncology 3, 4
Monitor serum potassium levels regularly during supplementation, especially in patients with impaired renal function, according to the American Journal of Kidney Diseases 1

Breast milk has lower potassium content (546 mg/L; 14 mmol/L) compared to standard infant formulas (700-740 mg/L; 18-19 mmol/L), as reported by the American Journal of Kidney Diseases 1, 2
Volumes of infant formula exceeding 165 mL/kg may aggravate hyperkalemia in susceptible patients, as noted by the American Journal of Kidney Diseases 1
Foods containing less than 100 mg or less than 3% DV are considered low in potassium, according to the American Journal of Kidney Diseases 1

Avoid potassium-containing salt substitutes in patients at risk for hyperkalemia, as recommended by the American Journal of Kidney Diseases 1

For asymptomatic pediatric patients with hyperkalemia, sodium polystyrene sulfonate 1 g/kg with 50% sorbitol can be administered orally, as suggested by the Journal of Clinical Oncology 3, 4
For symptomatic patients, more intensive interventions may be required, including insulin, glucose, sodium bicarbonate, or calcium gluconate, as advised by the Journal of Clinical Oncology 3, 4

The American Society of Clinical Oncology recommends verifying potassium level with a second sample to rule out spurious hypokalemia from hemolysis during phlebotomy, and assessing for symptoms of hypokalemia including muscle weakness, cardiac arrhythmias, and ECG changes 5

The National Kidney Foundation encourages potassium-rich foods appropriate for age, such as bananas, oranges, potatoes, and yogurt, and notes that breast milk has lower potassium content compared to standard infant formulas 6
The National Kidney Foundation also recommends that volumes of infant formula exceeding 165 mL/kg may provide >3 mmol/kg of potassium daily 6

The American Society of Nephrology states that in children with chronic kidney disease, hypokalemia is uncommon but may occur in those on peritoneal dialysis or frequent hemodialysis 6
The American Diabetes Association notes that children with diabetic ketoacidosis may develop hypokalemia during insulin therapy despite normal or elevated initial potassium levels 7
The International Society of Nephrology recommends that in children with congenital nephrotic syndrome, diuretic use should be cautious due to risk of electrolyte abnormalities including hypokalemia 8

The American Heart Association recommends monitoring for signs of overcorrection (hyperkalemia): peaked T waves, widened QRS complex, or cardiac arrhythmias 5